Establishing Multidisciplinary Frameworks for CMV Prevention and Treatment in High-Risk Posttransplant Patients
Establishing Multidisciplinary Frameworks for CMV Prevention and Treatment in High-Risk Posttransplant Patients
Interactive Practice GuideCytomegalovirus (CMV) is an opportunistic pathogen in both solid organ and hematopoietic stem cell transplant (HSCT) settings, and breakthrough infections and development of refractory and resistant infections cause significant complications posttransplant. To lessen patient burden and improve survival outcomes, optimal introduction of anti-CMV drugs for both prophylaxis and treatment is critical. To address these needs, multidisciplinary clinical teams must implement the latest advances in CMV monitoring, prevention, and treatment in patients with and without antiviral drug resistance. This interactive practice guide interweaves education and practical guidance for easy integration of the latest evidence into routine clinical practices, processes, and workflows.
Faculty: Fernanda P. Silveira, MD, MS; Roy F Chemaly, MD, MPH, FIDSA, FACP
Release Date:
Expiration Date: March 31, 2026
